Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Diabetes Drug Metformin Shows Potential in Osteoarthritis Care
January 2026
Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk.
Read more
19 Jun 2024
Fish Intake Linked to Juvenile Arthritis Risk: EULAR 2024 Findings
New data has linked the consumption of fish during pregnancy and the first year of life with juvenile idiopathic arthritis.
19 Jun 2024
Novel Treatments for Systemic Sclerosis: EULAR 2024 Findings
EULAR has updated its recommendations for systemic sclerosis, incorporating four new therapies presented at its congress in 2024.
13 Jun 2024
Raising Awareness of Juvenile Idiopathic Arthritis: Abstracts from EULAR 2024
The EULAR 2024 congress stressed the importance of supporting transitions from paediatric to adult care to maintain effective treatment for young patients
13 Jun 2024
Comorbidities of Osteoarthritis: Abstracts from EULAR 2024
A study reveals the significant comorbidities linked to osteoarthritis, highlighting the necessity for enhanced management and patient care strategies.
12 Jun 2024
Prediagnostic Proteomics of Gout: Abstracts from EULAR 2024
A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.
12 Jun 2024
Anti-Ro/SSA Antibodies in Systemic Sclerosis Stratification: Abstracts from EULAR 2024
Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.
4 Jun 2024
Early Diagnosis Crucial for Better Outcomes in Psoriatic Arthritis
A recent study highlights the importance of early diagnosis in psoriatic arthritis patients, showing that shorter delays lead to better clinical outcomes.
4 Jun 2024
Sex-Based Differences in axSpA Treatment Response
Recent study highlights sex differences in disease activity measures and treatment responses among patients with axial spondylarthritis
Loading posts...
« Previous
1
…
22
23
24
25
26
…
39
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View